Navigation Links
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
Date:8/6/2009

Excluding non-cash compensation expense related to stock options, operating expenses for Regulus were $2.7 million and $5.5 million for the three and six months ended June 30, 2009 compared to $1.7 million and $2.8 million for the same periods in 2008. The increase is primarily related to Regulus' continued efforts to build its team to support its internal microRNA programs and its GSK collaboration. Regulus generated a loss from operations, excluding non-cash compensation expense related to stock options, of $1.6 million and $3.8 million for the three and six months ended June 30, 2009 compared to $1.1 million and $2.1 million for the same periods in 2008.

Business Highlights

"During the last quarter, we and Genzyme made great progress regarding mipomersen on two important fronts, advancing the clinical development program and refining our regulatory strategy. We reported positive top-line results from a Phase 3 study of mipomersen in the largest, placebo-controlled Phase 3 study in homozygous FH patients. We reported that the study met its primary endpoint with a 25% reduction in LDL-C after 26 weeks of treatment with mipomersen versus 3% for placebo and all of its secondary endpoints in a highly statistically significant manner. We are very pleased with the performance of mipomersen in this study. These data are a significant milestone in the clinical development of mipomersen and support our efforts to make the drug available to patients in need," said Ms. Parshall.

"In addition to reporting data from the first of our Phase 3 trials for mipomersen, we and Genzyme refined and communicated the regulatory path for mipomersen in the United States and Europe. While the strategy continues to evolve, Genzyme plans to file the first NDA for mipomersen in the U.S. for homozygous FH in the second half of 2010, with a similar filing in Europe shortly afterwards. Data from our Phase 3 study in
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... The global mHealth market ... by 2020, growing at a CAGR of 47.6% from ... Grand View Research, Inc. Monitoring services is expected to ... to 2020.      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) ... incidences of chronic diseases such as cancer, heart ailments, ...
(Date:8/27/2015)... Aug. 27, 2015 Biosimilars are not ... the U.S. Food and Drug Administration (FDA) for ... in its draft guidance issued today. The FDA,s ... proposes distinguishable names, calling for biological products to ... suffix. This proposal reflects the agency,s thinking that ...
(Date:8/27/2015)... 2015  Now that Intuitive Surgical, Inc.® has announced ... robot, hospitals with robotic surgery programs need to think ... see where they stand with robotic surgery. Are they ... they adopted best practices for safety? Should they plan ... ECRI Institute, which has nearly 50 years, ...
Breaking Medicine Technology:mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3
... women and men has a bleeding disorder. However, 75 percent still ... it take to Close the Gap? On World ... the message to "Close the Gap" in care around the world. ... available for all globally. Many are unaware that if ...
... 2012  Mastech Holdings, Inc. (NYSE Amex: ... Technology and Specialized Healthcare Staffing services, has scheduled a conference call ... March 31, 2012.  The conference call will occur ... Eastern Time and will be hosted by Mr. ...
Cached Medicine Technology:World Hemophilia Day -- April 17 2Mastech Holdings, Inc. to Discuss First Quarter 2012 Financial Results on April 25, 2012 2
(Date:8/30/2015)... CA (PRWEB) , ... August 30, 2015 , ... ... announced a back to school special. The company is currently offering lice head checks ... In addition, the company is offering a 10% discount on their lice treatment products. ...
(Date:8/30/2015)... ... 2015 , ... Natural Rest contains a unique mixture of vitamins and herbs ... which help to improve mood disorders and anxiety. Like all other Creative Medical Health ... field of regenerative medicine conducted by Dr. Amit Patel of the University of Utah, ...
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional ... from Administrative assistant to Executive Assistant to CEO Mitch Gould for Nutritional Products ... focused on your goals. Kathleen graduated from Florida State University with a ...
(Date:8/29/2015)... , ... August 30, 2015 , ... On September 30, ... (EMCC), one of the 10 regionally accredited Maricopa Community Colleges , will be ... with college students pursuing employment information and opportunities. , The Expo has expanded to ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... two inventors from Miller Place, N.Y. "I specialize in manual therapy, and my ... addition, it can be used for additional muscle dysfunction throughout the body." , ...
Breaking Medicine News(10 mins):Health News:Lizzie’s Lice Pickers Announces Back to School Head Check Special and Discounted Lice Treatment Products 2Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2
... drugs could reduce the risk of breast cancer ... inhibitor. Aromatase inhibitors are drugs that block the ... breast cancer, aromatase inhibitors block the conversion of ... //In a new study, coordinated through the National ...
... you are born may affect your risk of schizophrenia. ... associated with advanced paternal age, particularly in females. ,Schizophrenia ... a person thinks, acts, expresses emotions, perceives reality and ... cannot be cured, but usually can be controlled with ...
... test may be an important tool in the fight ... highlights the use of an electrical brain test to ... treatment. The test, known as an electrophysiological test, detects ... ,Researchers found 65 percent of patients with impaired memory ...
... much fluid you drink. Too much fluid before, during or ... follows reports of several deaths from a severe lack of ... hyponatremic encephalopathy. Since the cause of the condition is now ... Africa, says it is preventable.,// ,Noakes says there is ...
... can wreak havoc on a woman’s bones and a new ... a fracture. Researchers know bone loss occurs after menopause, increasing ... bone size and strength. ,The Swedish study involved 146 women ... bone scans done to determine bone size and density. //All ...
... serving a day of tomato-based foods such as pizza or ... as much as 30 percent, according to a new Harvard ... Sesso, an assistant professor at the Harvard School of Public ... enough for us to do more studies."// ,Sesso and ...
Cached Medicine News:Health News:Lowering Risk of Breast Cancer Recurrence 2
... Nellcor Oxinet III Central Station and Paging ... level by providing earlier notification of developing ... the general care floor to provide affordable ... Oxinet III system features a central station ...
... Pulse Oximeter with Oxismart XL Advanced Signal ... through nonspecific noise to find the pulse ... pulse rate values. , ,The N395 ... Management, a breakthrough in clinician-programmable alarm sensitivity ...
The Model 5305 is a hand-held, portable, lightweight pulse oximeter designed for spot checking. It has a NiCad rechargeable battery....
The Model 305 is a hand-held, portable, lightweight oximeter designed for spot checking. It has a NiCad rechargeable battery....
Medicine Products: